Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

Does a combination of Arimidex and Zoladex make endometriomas shrink and how is the following IVF outcome

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rigshospitalet, Denmark
• Treatments: Anastrozole; Goserelin

Criteria

Inclusion Criteria:

• Endometrioma(s)with a size of 20-70 mm, persisted for at least 3 cycles

• Couples with indication and wish for IVF/ICSI

• Age of women: 20-40 years

• Regular menstrual cycle within normal range (21-35 days)

• Body Mass Index (BMI): 18-30 kg/m2

Exclusion Criteria:

• History with osteoporosis, liver-, kidney- or heart disease or thromboembolic disease

• Treatment of endometriosis with GnRH agonist during the last 3 month